{"count":220363,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2075","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2073","results":[{"created":"2019-12-04T20:30:06.971312+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.28","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gcsh has been classified as Red List (Low Evidence).","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:29:38.867701+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GCSH: Rating: RED; Mode of pathogenicity: None; Publications: 1671321; Phenotypes: Glycine encephalopathy, MIM#605899; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:42.578571+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GCSH as ready","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:42.571345+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gcsh has been classified as Red List (Low Evidence).","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:40.211431+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GCSH were changed from Glycine encephalopathy, MIM#605899 to Glycine encephalopathy, MIM#605899","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:36.862134+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GCSH were changed from  to Glycine encephalopathy, MIM#605899","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:23.183759+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.274","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GCSH were set to ","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:12.203102+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.273","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GCSH as Red List (low evidence)","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:28:12.194702+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.273","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gcsh has been classified as Red List (Low Evidence).","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:27:57.144076+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GCSH: Rating: RED; Mode of pathogenicity: None; Publications: 1671321; Phenotypes: Glycine encephalopathy, MIM#605899; Mode of inheritance: None","entity_name":"GCSH","entity_type":"gene"},{"created":"2019-12-04T20:22:03.301110+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GCK as ready","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:22:03.291547+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gck has been classified as Amber List (Moderate Evidence).","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:21:56.748853+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.272","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GCK were changed from  to Diabetes mellitus, permanent neonatal\t606176","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:21:44.669222+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.271","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GCK was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:21:33.747545+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.270","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GCK as Amber List (moderate evidence)","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:21:33.739055+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.270","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gck has been classified as Amber List (Moderate Evidence).","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:21:20.664110+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.269","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GCK: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: Diabetes mellitus, permanent neonatal 606176; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"GCK","entity_type":"gene"},{"created":"2019-12-04T20:14:56.981637+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.269","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GBE1 as ready","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:56.974209+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.269","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gbe1 has been classified as Red List (Low Evidence).","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:50.157013+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.269","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GBE1 were changed from  to Glycogen storage disease IV, MIM#232500","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:31.552937+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.268","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GBE1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:24.755575+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.267","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GBE1 as Red List (low evidence)","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:24.748438+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.267","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gbe1 has been classified as Red List (Low Evidence).","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:14:09.773274+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.266","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GBE1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Glycogen storage disease IV, MIM#232500; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GBE1","entity_type":"gene"},{"created":"2019-12-04T20:11:45.284269+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.266","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GBA2 as ready","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:45.276838+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.266","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gba2 has been classified as Red List (Low Evidence).","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:39.531562+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.266","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GBA2 were changed from  to Spastic paraplegia 46, autosomal recessive, MIM#614409","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:25.428779+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.265","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GBA2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:18.328812+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GBA2 as Red List (low evidence)","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:18.321659+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.264","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gba2 has been classified as Red List (Low Evidence).","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:11:05.721579+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GBA2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Spastic paraplegia 46, autosomal recessive, MIM#614409; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GBA2","entity_type":"gene"},{"created":"2019-12-04T20:07:57.215510+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA6 as ready","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T20:07:57.207948+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata6 has been classified as Green List (High Evidence).","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T20:07:11.595582+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.263","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GATA6 were changed from  to Pancreatic agenesis and congenital heart defects, MIM#600001","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T20:07:05.131068+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.262","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GATA6 were set to ","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T20:06:50.758382+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.261","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA6 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T20:05:11.435981+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA6: Rating: GREEN; Mode of pathogenicity: None; Publications: 22158542; Phenotypes: Pancreatic agenesis and congenital heart defects, MIM#600001; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"GATA6","entity_type":"gene"},{"created":"2019-12-04T17:08:31.049802+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GATA1 as ready","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:08:31.042062+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata1 has been classified as Red List (Low Evidence).","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:08:25.302244+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.260","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GATA1 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:08:18.894940+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.259","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GATA1 as Red List (low evidence)","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:08:18.887654+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.259","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gata1 has been classified as Red List (Low Evidence).","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:08:04.475557+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.258","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GATA1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Thrombocytopenia, X-linked, with or without dyserythropoietic anaemia, MIM#300367, Thrombocytopenia with beta-thalassemia, X-linked, MIM#314050, Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, MIM#300835; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"GATA1","entity_type":"gene"},{"created":"2019-12-04T17:00:36.782206+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.258","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GALT as ready","entity_name":"GALT","entity_type":"gene"},{"created":"2019-12-04T17:00:36.774490+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.258","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: galt has been classified as Green List (High Evidence).","entity_name":"GALT","entity_type":"gene"},{"created":"2019-12-04T17:00:25.733799+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.258","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GALT were changed from  to Galactosemia, MIM#230400","entity_name":"GALT","entity_type":"gene"},{"created":"2019-12-04T17:00:11.694488+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.257","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GALT was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GALT","entity_type":"gene"},{"created":"2019-12-04T16:59:58.114059+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.256","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GALT: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Galactosemia, MIM#230400; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GALT","entity_type":"gene"},{"created":"2019-12-04T11:56:31.850689+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GAD1 as ready","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:56:31.843338+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:56:21.161984+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.154","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GAD1 were changed from  to Cerebral palsy, spastic quadriplegic, 1, MIM#603513","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:55:43.145125+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.153","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GAD1 were set to ","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:55:25.323994+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.152","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GAD1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:54:54.563408+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.151","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GAD1 as Red List (low evidence)","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:54:54.555214+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.151","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:43:03.295089+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GAD1 as ready","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:43:03.287629+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:42:57.719991+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GAD1 were changed from  to Cerebral palsy, spastic quadriplegic, 1, MIM#603513","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:42:36.505372+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GAD1 were set to ","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:42:15.472341+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GAD1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:41:29.000318+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GAD1 as Red List (low evidence)","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:41:28.987029+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:40:59.293060+11:00","panel_name":"Cerebral Palsy_VCGS","panel_id":73,"panel_version":"0.1","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GAD1: Rating: RED; Mode of pathogenicity: None; Publications: 15571623; Phenotypes: Cerebral palsy, spastic quadriplegic, 1, MIM#603513; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:47.973409+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.256","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GAD1 as ready","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:47.966083+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.256","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:45.582478+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.256","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: GAD1 were changed from  to Cerebral palsy, spastic quadriplegic, 1, MIM#603513","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:34.751208+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.255","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: GAD1 were set to ","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:23.344719+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.254","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: GAD1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:14.498483+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.253","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GAD1 as Red List (low evidence)","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:14.490646+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.253","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gad1 has been classified as Red List (Low Evidence).","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T11:07:01.119115+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GAD1: Rating: RED; Mode of pathogenicity: None; Publications: 15571623; Phenotypes: Cerebral palsy, spastic quadriplegic, 1, MIM#603513; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GAD1","entity_type":"gene"},{"created":"2019-12-04T10:19:35.068344+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GABRG1 as ready","entity_name":"GABRG1","entity_type":"gene"},{"created":"2019-12-04T10:19:35.061066+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gabrg1 has been classified as Red List (Low Evidence).","entity_name":"GABRG1","entity_type":"gene"},{"created":"2019-12-04T10:19:27.798711+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: GABRG1 as Red List (low evidence)","entity_name":"GABRG1","entity_type":"gene"},{"created":"2019-12-04T10:19:27.786535+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.252","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: gabrg1 has been classified as Red List (Low Evidence).","entity_name":"GABRG1","entity_type":"gene"},{"created":"2019-12-04T10:19:14.955631+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GABRG1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"GABRG1","entity_type":"gene"},{"created":"2019-12-03T21:04:23.388554+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FUT8 as ready","entity_name":"FUT8","entity_type":"gene"},{"created":"2019-12-03T21:04:23.381356+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fut8 has been classified as Green List (High Evidence).","entity_name":"FUT8","entity_type":"gene"},{"created":"2019-12-03T21:04:16.711564+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FUT8 as Green List (high evidence)","entity_name":"FUT8","entity_type":"gene"},{"created":"2019-12-03T21:04:16.704633+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.251","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: fut8 has been classified as Green List (High Evidence).","entity_name":"FUT8","entity_type":"gene"},{"created":"2019-12-03T21:04:01.578273+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.250","user_name":"Zornitza Stark","item_type":"entity","text":"gene: FUT8 was added\ngene: FUT8 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: FUT8 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: FUT8 were set to 29304374\nPhenotypes for gene: FUT8 were set to Congenital disorder of glycosylation with defective fucosylation 1, MIM#618005\nReview for gene: FUT8 was set to GREEN\nAdded comment: Three unrelated individuals reported with bi-allelic variants in this gene. \nSources: Expert list","entity_name":"FUT8","entity_type":"gene"},{"created":"2019-12-03T20:55:23.120672+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FTL as ready","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:55:23.113316+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ftl has been classified as Red List (Low Evidence).","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:55:17.355790+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.249","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FTL were changed from  to Neurodegeneration with brain iron accumulation 3, MIM#606159; Hyperferritinemia-cataract syndrome, MIM#600886; L-ferritin deficiency, dominant and recessive, MIM#615604","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:55:01.167018+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.248","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FTL was changed from Unknown to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:54:55.198736+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FTL as Red List (low evidence)","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:54:55.191291+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.247","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ftl has been classified as Red List (Low Evidence).","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:54:42.750475+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FTL: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Neurodegeneration with brain iron accumulation 3, MIM#606159, Hyperferritinemia-cataract syndrome, MIM#600886, L-ferritin deficiency, dominant and recessive, MIM#615604; Mode of inheritance: BOTH monoallelic and biallelic, autosomal or pseudoautosomal","entity_name":"FTL","entity_type":"gene"},{"created":"2019-12-03T20:47:45.408146+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FRMPD4 as ready","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:47:45.400530+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: frmpd4 has been classified as Green List (High Evidence).","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:47:36.541135+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: FRMPD4 as Green List (high evidence)","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:47:36.533905+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.149","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: frmpd4 has been classified as Green List (High Evidence).","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:47:15.180282+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.148","user_name":"Zornitza Stark","item_type":"entity","text":"gene: FRMPD4 was added\ngene: FRMPD4 was added to Mendeliome_VCGS. Sources: Expert list\nMode of inheritance for gene: FRMPD4 was set to X-LINKED: hemizygous mutation in males, biallelic mutations in females\nPublications for gene: FRMPD4 were set to 25644381; 29267967\nPhenotypes for gene: FRMPD4 were set to Mental retardation, X-linked 104, MIM#300983\nReview for gene: FRMPD4 was set to GREEN\nAdded comment: Multiple affected individuals from unrelated families reported. \nSources: Expert list","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:41:23.949994+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FRMPD4 as ready","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:41:23.942360+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: frmpd4 has been classified as Green List (High Evidence).","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:41:17.132757+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.246","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: FRMPD4 were changed from  to Mental retardation, X-linked 104, MIM#300983","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:41:04.826994+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.245","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: FRMPD4 were set to ","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:40:50.644577+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.244","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: FRMPD4 was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T20:40:35.235628+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.243","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: FRMPD4: Rating: GREEN; Mode of pathogenicity: None; Publications: 25644381, 29267967; Phenotypes: Mental retardation, X-linked 104, MIM#300983; Mode of inheritance: X-LINKED: hemizygous mutation in males, biallelic mutations in females","entity_name":"FRMPD4","entity_type":"gene"},{"created":"2019-12-03T19:22:23.889599+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.243","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: FRAS1 as ready","entity_name":"FRAS1","entity_type":"gene"}]}